A study to correlate the activity of first-line chemotherapy with response, time to progression and overall survival in patients with advanced epithelial ovarian cancer

• Grant number: 15/16921-3
• Support Opportunities: Scholarships in Brazil - Young Researchers
• Start date until: September 01, 2015
• End date until: August 31, 2018
• Field of knowledge: Health Sciences - Medicine - Maternal and Child Health
• Principal Investigator: Paulo D'Amora
• Grantee: Paulo D'Amora
• Host Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
• Associated research grant: 14/19171-2 - A study to correlate the activity of first-line chemotherapy with response, time to progression and overall survival in patients with advanced epithelial ovarian cancer, AP.JP

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

D'AMORA, PAULO; SILVA, ISMAEL DALE C. G.; TEWARI, KRISHNANSU S.; BRISTOW, ROBERT E.; CAPPUCCINI, FABIO; EVANS, STEVEN S.; SALZGEBER, MARCIA B.; ADDIS-BERNARD, PAULA J.; PALMA, ANTON M.; MARCHIONI, DIRCE M. L.; et al. Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. GYNECOLOGIC ONCOLOGY, v. 163, n. 1, p. 162-170, OCT 2021. (14/19171-2, 15/16921-3)

D'AMORA, PAULO; COTRIM GUERREIRO SILVA, ISMAEL DALE; CASTRO, RODRIGO DE AQUINO; SALZGEBER, BATISTA MARCIA; BRISTOW, ROBERT; EVANS, STEVEN; DISAIA, PHILIP J.; ROBERT, ALAN NAGOURNEY. Metabolomic signatures in patients with advanced epithelial ovarian cancer: Correlation with clinical response parameters in a phase II study.. Clinical Cancer Research, v. 24, n. 1, p. 2-pg., 2018-01-01. (14/19171-2, 15/16921-3)